QIAGEN N.V. (QGEN) stock
QGENNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$49.75−0.06 (-0.12%)
Close on Nov 17, 2026Market cap $10.79BP/E 25.6Yield 0.50%
Qiagen price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Qiagen's price to sales ratio was 5.3× on Nov 11, 2026, against 5.7× a year earlier. Over the last 5 years it ranged from 3.6× to 7.3×, with a median of 5.2×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 5.3× | −0.1 |
| 2025 | Dec 31, 2025 | 5.4× | +0.2 |
| 2024 | Dec 31, 2024 | 5.2× | +0.3 |
| 2023 | Dec 29, 2023 | 4.9× | −0.5 |
| 2022 | Dec 30, 2022 | 5.4× | −1.9 |
| 2021 | Dec 31, 2021 | 7.3× | −0.9 |
| 2020 | Dec 31, 2020 | 8.3× | +2.7 |
| 2019 | Dec 31, 2019 | 5.5× | −0.4 |
| 2018 | Dec 31, 2018 | 6.0× | +0.1 |
| 2017 | Dec 29, 2017 | 5.8× | +0.3 |
| 2016 | Dec 30, 2016 | 5.5× | +0.2 |
| 2015 | Dec 31, 2015 | 5.3× | +0.7 |
| 2014 | Dec 31, 2014 | 4.6× | −0.1 |
| 2013 | Dec 31, 2013 | 4.7× | +0.9 |
| 2012 | Dec 31, 2012 | 3.8× | +3.8 |
| 2011 | Dec 30, 2011 | 0.0× | −4.7 |
| 2010 | Dec 31, 2010 | 4.7× | −0.6 |
| 2009 | Dec 31, 2009 | 5.4× | – |
See a number that looks wrong?